Chemomab Awarded New European Patent for CM-101, Its

Chemomab has gained a new EU patent for CM-101 covering its use in liver diseases including PSC, adding to the robust patent estate in major territories....

Related Keywords

China ,Israel ,Wadi Mor ,Barbara Lindheim ,European Patent Office Grants New Covering ,Nasdaq ,European Patent Office ,Strategic Communications ,Chemomab Therapeutics Ltd ,Multiple Liver ,Primary Sclerosing Cholangitis ,Further Extends Protections Afforded ,Use Patents ,That Have Issued ,Related Territories ,Chief Executive Officer ,Chief Scientific Officer ,Patent Application ,Orphan Drug ,Private Securities Litigation Reform ,Vice President ,Public Relations ,Nasdaq Cmmb ,Chemomab Therapeutics ,Patents ,Um 101 ,Hemomab ,